Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00250341 · ClinicalTrials.gov registry record · Phase 4
Non-invasive Measures of Distal Lung Disease in Asthmatics
A Phase 4 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT00250341 is a Phase 4 study that has completed, run by Teva Branded Pharmaceutical Products R&D. The registered enrollment target is 34 participants.
The verdict
NCT00250341, a Phase 4 study, has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
This is a Phase 4, single center study conducted in mild-to moderate asthmatics.
Interventions
- DRUG QVAR
- DRUG Advair
- DRUG Servent Diskus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2005-09-30 |
| Est. Completion | 2007-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00250341
The ClinicalTrials.gov registry entry for NCT00250341 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teva Branded Pharmaceutical Products R&D, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which QVAR is the first listed.
NCT00250341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00250341 about?
NCT00250341 is a clinical study titled "Non-invasive Measures of Distal Lung Disease in Asthmatics". This is a Phase 4, single center study conducted in mild-to moderate asthmatics.
What is the current status of trial NCT00250341?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2005-09-30. Estimated completion is 2007-09-30.
What interventions are being tested in trial NCT00250341?
The interventions under investigation include: QVAR (DRUG), Advair (DRUG), Servent Diskus (DRUG).
Who is sponsoring clinical trial NCT00250341?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.